A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

BACKGROUND: Oseltamivir is the preferred antiviral drug for influenza, but oseltamivir-resistant A(H1N1) viruses have circulated worldwide since the 2007-2008 influenza season. We aimed to determine the rate of oseltamivir resistance among A(H1N1) isolates from Yamagata, Japan, to compare the virolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzaki, Yoko, Mizuta, Katsumi, Aoki, Yoko, Suto, Asuka, Abiko, Chieko, Sanjoh, Kanako, Sugawara, Kanetsu, Takashita, Emi, Itagaki, Tsutomu, Katsushima, Yuriko, Ujike, Makoto, Obuchi, Masatsugu, Odagiri, Takato, Tashiro, Masato
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847566/
https://www.ncbi.nlm.nih.gov/pubmed/20202225
http://dx.doi.org/10.1186/1743-422X-7-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847566/
https://www.ncbi.nlm.nih.gov/pubmed/20202225
http://dx.doi.org/10.1186/1743-422X-7-53

Ejemplares similares